全文获取类型
收费全文 | 294125篇 |
免费 | 10304篇 |
国内免费 | 783篇 |
专业分类
耳鼻咽喉 | 3907篇 |
儿科学 | 10697篇 |
妇产科学 | 8228篇 |
基础医学 | 38975篇 |
口腔科学 | 8156篇 |
临床医学 | 25486篇 |
内科学 | 57623篇 |
皮肤病学 | 6613篇 |
神经病学 | 21177篇 |
特种医学 | 12964篇 |
外国民族医学 | 103篇 |
外科学 | 39617篇 |
综合类 | 1807篇 |
一般理论 | 80篇 |
预防医学 | 27253篇 |
眼科学 | 5900篇 |
药学 | 19697篇 |
4篇 | |
中国医学 | 383篇 |
肿瘤学 | 16542篇 |
出版年
2022年 | 1524篇 |
2021年 | 3164篇 |
2020年 | 1970篇 |
2019年 | 2936篇 |
2018年 | 6802篇 |
2017年 | 6087篇 |
2016年 | 5466篇 |
2015年 | 7212篇 |
2014年 | 7705篇 |
2013年 | 8371篇 |
2012年 | 16823篇 |
2011年 | 12127篇 |
2010年 | 6359篇 |
2009年 | 7474篇 |
2008年 | 8205篇 |
2007年 | 9042篇 |
2006年 | 9081篇 |
2005年 | 16913篇 |
2004年 | 18033篇 |
2003年 | 13329篇 |
2002年 | 8237篇 |
2001年 | 6036篇 |
2000年 | 3419篇 |
1999年 | 7258篇 |
1998年 | 1517篇 |
1992年 | 7528篇 |
1991年 | 7628篇 |
1990年 | 7837篇 |
1989年 | 7364篇 |
1988年 | 6871篇 |
1987年 | 6604篇 |
1986年 | 6303篇 |
1985年 | 5540篇 |
1984年 | 3867篇 |
1983年 | 3151篇 |
1982年 | 1227篇 |
1979年 | 4006篇 |
1978年 | 2548篇 |
1977年 | 1928篇 |
1976年 | 1709篇 |
1975年 | 2619篇 |
1974年 | 3233篇 |
1973年 | 2876篇 |
1972年 | 2887篇 |
1971年 | 2866篇 |
1970年 | 2655篇 |
1969年 | 2557篇 |
1968年 | 2338篇 |
1967年 | 2270篇 |
1966年 | 1987篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Rizzo Manglio Miguel Bluthgen Mara Virginia Recondo Gonzalo Naveira Martin Perfetti Aldo Rizzi Florencia Kuzminin Alejandro Faura Victoria Cerini Matas Videla Alejandro Silva Carlos Lupinacci Lorena Minatta Nicols 《International journal of clinical oncology / Japan Society of Clinical Oncology》2021,26(6):1057-1064
International Journal of Clinical Oncology - Immune-checkpoint inhibitors (ICIs) are standard treatments for metastatic non-small cell lung cancer (NSCLC). Patients with poor performance status... 相似文献
2.
3.
4.
5.
Jose M. Morales Jose Angel Martinez-Flores Manuel Serrano Maria José Castro Francisco Javier Alfaro Florencio García Miguel Angel Martínez Amado Andrés Esther González Manuel Praga Estela Paz-Artal Antonio Serrano 《Journal of the American Society of Nephrology : JASN》2015,26(3):735-745
In the current immunosuppressive therapy era, vessel thrombosis is the most common cause of early graft loss after renal transplantation. The prevalence of IgA anti–β2-glycoprotein I antibodies (IgA-aB2GPI-ab) in patients on dialysis is elevated (>30%), and these antibodies correlate with mortality and cardiovascular morbidity. To evaluate the effect of IgA-aB2GPI-ab in patients with transplants, we followed all patients transplanted from 2000 to 2002 in the Hospital 12 de Octubre prospectively for 10 years. Presence of IgA-aB2GPI-ab in pretransplant serum was examined retrospectively. Of 269 patients, 89 patients were positive for IgA-aB2GPI-ab (33%; group 1), and the remaining patients were negative (67%; group 2). Graft loss at 6 months post-transplant was significantly higher in group 1 (10 of 89 versus 3 of 180 patients in group 2; P=0.002). The most frequent cause of graft loss was thrombosis of the vessels, which was observed only in group 1 (8 of 10 versus 0 of 3 patients in group 2; P=0.04). Multivariate analysis showed that the presence of IgA-aB2GPI-ab was an independent risk factor for early graft loss (P=0.04) and delayed graft function (P=0.04). There were no significant differences regarding patient survival between the two groups. Graft survival was similar in both groups after 6 months. In conclusion, patients with pretransplant IgA-aB2GPI-ab have a high risk of early graft loss caused by thrombosis and a high risk of delayed graft function. Therefore, pretransplant IgA-aB2GPI-ab may have a detrimental effect on early clinical outcomes after renal transplantation. 相似文献
6.
Susan E. Hickman Alexia M. Torke Greg A. Sachs Rebecca L. Sudore Anne L. Myers Qing Tang Giorgos Bakoyannis Bernard J. Hammes 《Journal of pain and symptom management》2019,57(6):1143-1150.e5
ContextIt is especially important that patients are well informed when making high-stakes, preference-sensitive decisions like those on the Physician Orders for Life-Sustaining Treatment (POLST) form. However, there is currently no way to easily evaluate whether patients understand key concepts when making these important decisions.ObjectivesTo develop a POLST knowledge survey.MethodsExpert (n = 62) ratings of key POLST facts were used to select items for a POLST knowledge survey. The survey was administered to nursing facility residents (n = 97) and surrogate decision-makers (n = 112). A subset (n = 135) were re-administered the survey after a standardized advance care planning discussion to assess the scale's responsiveness to change.ResultsThe 19-item survey demonstrated adequate reliability (α = 0.72.). Residents' scores (x = 11.4, standard deviation 3.3) were significantly lower than surrogate scores (x = 14.7, standard deviation 2.5) (P < 0.001). Scores for both groups increased significantly after administration of a standardized advance care planning discussion (P < 0.001). Although being a surrogate, age, race, education, cognitive functioning, and health literacy were significantly associated with higher POLST Knowledge Survey scores in univariate analyses, only being a surrogate (P < 0.001) and being white (P = 0.028) remained significantly associated with higher scores in multivariate analyses.ConclusionThe 19-item POLST Knowledge Survey demonstrated adequate reliability and responsiveness to change. Findings suggest the survey could be used to identify knowledge deficits and provide targeted education to ensure adequate understanding of key clinical decisions when completing POLST. 相似文献
7.
8.
9.
10.